𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of Bisphosphonates and Risk of Breast Cancer

✍ Scribed by Peter Vestergaard; Lone Fischer; Marco Mele; Leif Mosekilde; Peer Christiansen

Publisher
Springer
Year
2011
Tongue
English
Weight
174 KB
Volume
88
Category
Article
ISSN
1432-0827

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Statin use and risk of breast cancer
Statin use and risk of breast cancer
✍ Gaia Pocobelli; Polly A. Newcomb; Amy Trentham-Dietz; Linda Titus-Ernstoff; John πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Findings that statins inhibited the proliferation of breast cancer cells in vitro and in rodents have raised interest in whether the use of statins might decrease a woman's risk of developing breast cancer. We analyzed data from a population‐based case‐control study to e

Antihistamine use and breast cancer risk
Antihistamine use and breast cancer risk
✍ Victoria Nadalin; Michelle Cotterchio; Nancy Kreiger πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 61 KB πŸ‘ 2 views

## Abstract Antihistamines are structurally similar to DPPE, a tamoxifen derivative known to promote tumor growth, and to antidepressants. Animal experiments have linked certain antihistamines and antidepressants with enhanced tumor growth in mice. The few epidemiologic studies examining antihistam

Antidepressant use and breast cancer ris
Antidepressant use and breast cancer risk
✍ Chloe Chien; Christopher I. Li; Susan R. Heckbert; Kathleen E. Malone; Denise M. πŸ“‚ Article πŸ“… 2005 πŸ› Springer US 🌐 English βš– 175 KB
Menopausal estrogen use and risk of brea
Menopausal estrogen use and risk of breast cancer
✍ Louise A. Brinton; Robert N. Hoover; Moyses Szklo; Joseph F. Fraumeni Jr πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 562 KB

To assess the relationship of menopausal estrogens to breast cancer risk, the authors conducted a case-control study among 881 cases and 863 controls identified through the Breast Cancer Detection Demonstration Project (BCDDP). Use of estrogens was associated with a relative risk (RR) of 1.24 (95% C